AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24167181
Drug: Exposure to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure to polyalkyloxy compounds used as adjuvants
Trial: 19186725
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and moxibustion treatment
Trial: 19563205
Drug: Routine medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medicine treatment
Trial: 17417987
Drug: Oxaceprol 1200
RxNorm normalized name: Oxaceprol
DrugBank: Oxaceprol (DB13363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaceprol 1200 mg/day
Trial: 15351584
Drug: Unilateral pudendal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral pudendal nerve blockade with 10 mg of 1% prilocaine (group 1, n = 26)
Trial: 15351584
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control with 10 mL of 0.9 NaCl solution (group 2, n = 25)
Trial: 9566835
Drug: Gamma-linolenic and
RxNorm normalized name: gamma-linolenate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma-linolenic and linoleic acid (1 g/day of each fatty acid) for 6 weeks
Trial: 7997384
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg with concomitant ddI 300 mg
Trial: 2454893
Drug: Pseudomonas aeruginosa
RxNorm normalized name: Pseudomonas aeruginosa
DrugBank: Pseudomonas aeruginosa (DB19284)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine
Trial: 2454893
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of vaccine at 15 months
Trial: 31479007
Drug: Information only
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information only control group (monthly newsletters on type 2 diabetes education and prevention)
Trial: 25869875
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (90 min, twice a week for 12 weeks)
Trial: 15893416
Drug: Imatinib (2x400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (2x400 mg po daily)
Trial: 15893416
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m2 weekly)
Trial: 16508584
Drug: Hormonal replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal replacement therapy (HRT)
Trial: 9359745
Drug: Combination antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antiretroviral therapy (zidovudine, didanosine, nevirapine)
Trial: 8229656
Drug: Didanosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (ddI) treatment group
Trial: 8229656
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) treatment group
Trial: 6495086
Drug: Gallbladder contraction
RxNorm normalized name: Bos taurus gallbladder preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallbladder contraction stimulated by intravenous pancreozymin
Trial: 31300280
Drug: Advax-adjuvanted honeybee
RxNorm normalized name: Tdvax
DrugBank: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advax-adjuvanted honeybee venom immunotherapy (HBVIT)
Trial: 31300280
Drug: Honeybee venom
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honeybee venom immunotherapy (VIT) without Advax adjuvant
Trial: 24964759
Drug: Intravenous CCRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous CCRT (n = 80)
Trial: 15486066
Drug: MTX-4h (methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX-4h (methotrexate as intravenous infusion over 4 hours)
Trial: 15486066
Drug: MTX-24h (methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX-24h (methotrexate as intravenous infusion over 24 hours)
Trial: 15486066
Drug: MTX 1
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX 1 g/m(2) (in NHL-BFM95)
Trial: 15486066
Drug: MTX 5
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX 5 g/m(2) (in NHL-BFM90)
Trial: 11443161
Drug: Antithyroid drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithyroid drug pretreatment
Trial: 2511910
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 200 mg three times daily
Trial: 1127088
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg calcium/kg (calcium gluconate at 3 ml/min for 3 h followed by normal saline for the fourth hour)
Trial: 1127088
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline at 3 ml/min for 4 h
Trial: 1127088
Drug: l-dopa (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-dopa (500 mg oral dose) during normal saline and calcium infusions
Trial: 28816033
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg bilayer sustained-release acetaminophen (APAP)
Trial: 28816033
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg immediate-release acetaminophen (APAP) taken 6 hours apart
Trial: 28816033
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg single-layer sustained-release acetaminophen (APAP)
Trial: 28816033
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg single-layer sustained-release acetaminophen (APAP) with different excipient
Trial: 28816033
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg enteric-coated sustained-release acetaminophen (APAP) with fast-dissolving IR APAP
Trial: 24114402
Drug: High-dose intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intervention (HI) group
Trial: 23176993
Drug: Levobupivacaine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 5% administered over 1 min (fast) in Group F
Trial: 23176993
Drug: Levobupivacaine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 5% administered over 3 min (slow) in Group S
Trial: 18691986
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of ketotifen fumarate ophthalmic solution 0.025%
Trial: 18691986
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of ketotifen fumarate ophthalmic solution 0.025%
Trial: 1800929
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% cyclosporine
Trial: 22315155
Drug: leuprolide 3.75
RxNorm normalized name: leuprolide 3.75 mg intramuscular powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: leuprolide 3.75 mg
Trial: 22315155
Drug: leuprolide 7.5
RxNorm normalized name: leuprolide 7.5 mg/month intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: leuprolide 7.5 mg
Trial: 22315155
Drug: goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: goserelin 3.6 mg
Trial: 15809123
Drug: Racemic bupivacaine
RxNorm normalized name: Racemic bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Racemic bupivacaine (2.5 mg) + fentanyl (25 microg)
Trial: 15809123
Drug: L-bupivacaine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-bupivacaine (2.5 mg) + fentanyl (25 microg)
Trial: 15809123
Drug: Racemic bupivacaine
RxNorm normalized name: Racemic bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Racemic bupivacaine and L-bupivacaine
Trial: 12114402
Drug: CTP37-DT vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CTP37-DT vaccine administered intramuscularly on days 0, 28, and 70.
Trial: 7553242
Drug: Oxymetazoline nasal
RxNorm normalized name: oxymetazoline nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetazoline nasal spray alone
Trial: 274263
Drug: 0.2% SnF2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% SnF2 solution
Trial: 274263
Drug: 0.3% SnF2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3% SnF2 solution
Trial: 30989175
Drug: Prolonged intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged intravenous therapy
Trial: 25536008
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice (140 mL, providing 12.9 mmol of nitrate)
Trial: 16448575
Drug: Primaquine (PQ)
DrugBank: Primaquine (DB01087)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Primaquine (PQ) 45 mg
Trial: 16448575
Drug: Bulaquine (BQ)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bulaquine (BQ) 75 mg
Trial: 15561834
Drug: Amoxicillin-clavulanate exposure
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate exposure during the previous 3 months
Trial: 3904205
Drug: Radiation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation treatment alone
Trial: 9778203
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate (5 mg/d)
Trial: 9778203
Drug: Nifedipine coat
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine coat core (30 mg/d)
Trial: 9778203
Drug: Nifedipine gastrointestinal
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine gastrointestinal therapeutic system (GITS) (30 mg/d)
Trial: 31077519
Drug: Individualized Occupational
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized Occupational Therapy (IOT)
Trial: 31077519
Drug: Group Occupational
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Occupational Therapy (GOT) alone
Trial: 31077519
Drug: Type of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type of occupational therapy
Trial: 27535371
Drug: Control (inert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (inert lotion)
Trial: 24777691
Drug: Colesevelam 1.5-4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colesevelam 1.5-4.5 g/day
Trial: 22798322
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids with vitamin D deficiency
Trial: 22798322
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids with vitamin D insufficiency
Trial: 22798322
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids with vitamin D sufficiency
Trial: 21055090
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (control group)
Trial: 19969409
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate (E2V) and dienogest (DNG) administered over 20 cycles with a specific dosing schedule: E2V 3 mg on days 1 and 2, E2V 2 mg/DNG 2 mg on days 3-7, E2V 2 mg/DNG 3 mg on days 8-24, E2V 1 mg on days 25 and 26, and placebo on days 27 and 28.
Trial: 15457373
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg/d)
Trial: 11145109
Drug: High-fat (40%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat (40% of daily energy), high-monounsaturated-fat diet
Trial: 11145109
Drug: Low-fat (30%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat (30% of daily energy) diet
Trial: 3596872
Drug: O-(beta-hydroxyethyl)-rutosides (HR)
RxNorm normalized name: Padimate O
DrugBank: Padimate O (DB11570)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: O-(beta-hydroxyethyl)-rutosides (HR) 3 g/day for 28 days
Trial: 29871226
Drug: Traditional oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional oral health education (Control)
Trial: 26039521
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg) + Ezetimibe (10 mg)
Trial: 26039521
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg) + Placebo
Trial: 23222038
Drug: Cognitive analytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive analytic therapy (CAT) - 24 sessions over 10 months
Trial: 21983067
Drug: Maternal probiotic
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal probiotic treatment
Trial: 11020001
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with interferon alpha-2b and ribavirin for 24 weeks
Trial: 11020001
Drug: Interferon alpha-2b
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alpha-2b monotherapy for 48 weeks
Trial: 9279534
Drug: L-arginine (0.52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (0.52 mg kg‐1 min‐1)
Trial: 8334811
Drug: Clenbuterol treatment
RxNorm normalized name: clenbuterol
DrugBank: Clenbuterol (DB01407)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clenbuterol treatment for 4 weeks postoperatively
Trial: 8334811
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for 4 weeks postoperatively
Trial: 3595666
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose methylprednisolone added to metoclopramide
Trial: 27543277
Drug: Pakistani almonds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pakistani almonds (10 g/day)
Trial: 27543277
Drug: American almonds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: American almonds (10 g/day)
Trial: 26685032
Drug: Impulsivity-focused group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impulsivity-focused group intervention (8 weekly sessions)
Trial: 23414589
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with three cycles of TPF followed by concurrent chemoradiotherapy
Trial: 23414589
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy alone with two cycles of bolus cisplatin
Trial: 23414589
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy followed by chemoradiotherapy
Trial: 16750345
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of DHA daily for 14 days
Trial: 16750345
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of olive oil as placebo daily for 14 days
Trial: 10871462
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy changes
Trial: 3885921
Drug: Oxygen inhalation
RxNorm normalized name: oxygen INHALATION GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen inhalation at 6 L/min via nonrebreathing face masks for 15 minutes or less
Trial: 3885921
Drug: Air inhalation
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air inhalation at 6 L/min via nonrebreathing face masks for 15 minutes or less
Trial: 30118351
Drug: No periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No periodontal therapy (control)
Trial: 15177521
Drug: Amlodipine besylate/benazepril
RxNorm normalized name: amlodipine besylate/benazepril 5 mg-10 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate/benazepril HCl combination therapy (5/20 mg/d titrated to 10/20 mg/d)
Trial: 15177521
Drug: Amlodipine besylate/benazepril
RxNorm normalized name: amlodipine besylate/benazepril 5 mg-10 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate/benazepril HCl combination therapy
Trial: 15177521
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate monotherapy (5 mg/d titrated to 10 mg/d)
Trial: 15177521
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate monotherapy
Trial: 9498468
Drug: ETEC/rCTB vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETEC/rCTB vaccine (E003)
Trial: 3264141
Drug: Cardioplegic solution
RxNorm normalized name: cardioplegic solution no.2
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardioplegic solution without allopurinol (Group 1)
Trial: 3264141
Drug: Cardioplegic solution
RxNorm normalized name: cardioplegic solution no.2
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardioplegic solution with 100 mg allopurinol (Group 2)
Trial: 30789807
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of calcium and 800 IU vitamin D supplementation
Trial: 24518763
Drug: Surgeon administered
RxNorm normalized name: sturgeon, unspecified preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgeon administered regional field infiltration with bupivacaine
Trial: 22338626
Drug: Probiotic yogurt
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic yogurt (200 g/day)
Trial: 22338626
Drug: Conventional yogurt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional yogurt (200 g/day)
Trial: 17627016
Drug: Specific IgE
RxNorm normalized name: BSA specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgE to common aeroallergens (defined as >or=0.35 kU/L)
Trial: 17627016
Drug: Total serum
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total serum IgE levels before treatment
Trial: 15899724
Drug: rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone 4 mg/day
Trial: 15899724
Drug: glimepiride 2
RxNorm normalized name: glimepiride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glimepiride 2 mg/day
Trial: 9650373
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel (0.5 mg administered intracervically)
Trial: 9650373
Drug: Estradiol gel
RxNorm normalized name: ESTRADIOL 1 mg in 1 g TOPICAL GEL [Estradiol Gel]
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol gel (150 mg administered intravaginally)
Trial: 1850128
Drug: High fat-low
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fat-low fiber diet (96 g fat/day, 6 g fiber/day)
Trial: 1850128
Drug: Low fat-high
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fat-high fiber diet (33 g fat/day, 41 g fiber/day)
Trial: 27370941
Drug: Paracetamol 1g
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol 1g IV
Trial: 25342708
Drug: AG2 (bed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG2 (bed rest and six periods of 5 min AG daily)
Trial: 25342708
Drug: AG1 (bed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG1 (bed rest and 30 min of AG daily)
Trial: 25524951
Drug: Blood 25-hydroxyvitamin
RxNorm normalized name: SUS SCROFA BLOOD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood 25-hydroxyvitamin D concentration <50 nmol/L
Trial: 23474735
Drug: Conventional out-patient
RxNorm normalized name: Cough Out
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional out-patient physical therapy
Trial: 11783697
Drug: ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ceftazidime 2 g t.i.d. (n=12)
Trial: 11783697
Drug: imipenem/cilastatin 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: imipenem/cilastatin 1 g t.i.d. (n=15)
Trial: 594790
Drug: Diethylstilbestrol (DES,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylstilbestrol (DES, 5 mg/day)
Trial: 28422269
Drug: Wake therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wake therapy
Trial: 27804203
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy (30 min daily for 9 weeks)